Top U.S. proton pump inhibitors' revenue market share 2013
This statistic displays the market share of the top ten proton pump inhibitors in the United States in 2013. In that year, Aciphex was among the leading proton pump inhibitors with a total market share of 8 percent in the United States. Proton pump inhibitors are drugs that aid in the long-term reduction of gastric acid production. It is often used to treat conditions such as peptic ulcer disease and Barrett's esophagus.
